Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Short Interest Up 144.0% in December

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 12,200 shares, an increase of 144.0% from the December 15th total of 5,000 shares. Based on an average daily trading volume, of 5,300 shares, the short-interest ratio is currently 2.3 days.

Clinuvel Pharmaceuticals Stock Performance

Shares of OTCMKTS CLVLY traded up $0.12 during midday trading on Thursday, hitting $7.39. 1,429 shares of the company’s stock were exchanged, compared to its average volume of 6,161. The stock’s 50 day moving average price is $8.10 and its 200-day moving average price is $9.13. Clinuvel Pharmaceuticals has a twelve month low of $6.80 and a twelve month high of $11.40.

Clinuvel Pharmaceuticals Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).